Home > National Drug Code (NDC) > Imipenem and Cilastatin

Imipenem and Cilastatin - 63323-349-20 - (Imipenem and Cilastatin Sodium)

Alphabetical Index


Drug Information of Imipenem and Cilastatin

Product NDC: 63323-349
Proprietary Name: Imipenem and Cilastatin
Non Proprietary Name: Imipenem and Cilastatin Sodium
Active Ingredient(s): 250; 250    mg/1; mg/1 & nbsp;   Imipenem and Cilastatin Sodium
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, POWDER, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Imipenem and Cilastatin

Product NDC: 63323-349
Labeler Name: APP Pharmaceuticals, LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA090577
Marketing Category: ANDA
Start Marketing Date: 20120103

Package Information of Imipenem and Cilastatin

Package NDC: 63323-349-20
Package Description: 10 VIAL, GLASS in 1 CARTON (63323-349-20) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS

NDC Information of Imipenem and Cilastatin

NDC Code 63323-349-20
Proprietary Name Imipenem and Cilastatin
Package Description 10 VIAL, GLASS in 1 CARTON (63323-349-20) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS
Product NDC 63323-349
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Imipenem and Cilastatin Sodium
Dosage Form Name INJECTION, POWDER, FOR SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 20120103
Marketing Category Name ANDA
Labeler Name APP Pharmaceuticals, LLC
Substance Name CILASTATIN SODIUM; IMIPENEM
Strength Number 250; 250
Strength Unit mg/1; mg/1
Pharmaceutical Classes Carbapenems [Chemical/Ingredient],Penem Antibacterial [EPC],Dipeptidase Inhibitors [MoA],Renal Dehydropeptidase Inhibitor [EPC]

Complete Information of Imipenem and Cilastatin


General Information